Summit Corporation plc Stock London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 10.09B 13.65B 11.75B 11.05B 18.88B 1,289B 18.94B 131B 50.67B 661B 51.26B 50.14B 2,130B | P/E 2026 * |
-14.6x | P/E 2027 * | -14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.63B 13.02B 11.2B 10.54B 18.01B 1,229B 18.06B 125B 48.33B 631B 48.88B 47.82B 2,032B | EV / Sales 2026 * |
3,294x | EV / Sales 2027 * | 237x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 2022-07-24 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 2020-03-31 |
| Director of Finance/CFO | 48 | 2024-04-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 2020-01-31 |
| Director/Board Member | 48 | 2019-11-30 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 2020-11-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -3.82% | +38.74% | +91.90% | 69.02B | |
| -2.06% | -0.18% | +41.53% | +88.17% | 66.32B | |
| -0.40% | +6.15% | -11.72% | +377.17% | 27.66B | |
| +1.57% | +2.25% | +0.84% | -14.45% | 25.84B | |
| -3.00% | -2.61% | +34.45% | +11.39% | 26.54B | |
| -1.46% | +0.42% | +24.07% | -18.70% | 20.4B | |
| -2.96% | -16.03% | +213.13% | +375.00% | 17.63B | |
| -1.49% | -6.69% | -4.69% | +539.74% | 15.15B | |
| -0.10% | +8.30% | +57.76% | +164.80% | 14.65B | |
| Average | -1.30% | -0.66% | +43.79% | +179.45% | 31.47B | |
| Weighted average by Cap. | -1.47% | -0.45% | +39.06% | +139.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.92M 3.95M 3.4M 3.2M 5.47M 373M 5.48M 37.81M 14.67M 191M 14.84M 14.52M 617M | 41.7M 56.39M 48.52M 45.65M 78.01M 5.32B 78.22M 539M 209M 2.73B 212M 207M 8.8B |
| Net income | -690M -933M -803M -755M -1.29B -88.07B -1.29B -8.92B -3.46B -45.18B -3.5B -3.43B -146B | -730M -986M -849M -799M -1.36B -93.14B -1.37B -9.44B -3.66B -47.79B -3.7B -3.62B -154B |
| Net Debt | -467M -632M -544M -512M -874M -59.66B -877M -6.04B -2.35B -30.61B -2.37B -2.32B -98.6B | -199M -268M -231M -217M -371M -25.35B -372M -2.57B -997M -13.01B -1.01B -986M -41.9B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
